Douglas L. Jennings

2.6k total citations
108 papers, 1.2k citations indexed

About

Douglas L. Jennings is a scholar working on Surgery, Biomedical Engineering and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Douglas L. Jennings has authored 108 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Surgery, 59 papers in Biomedical Engineering and 42 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Douglas L. Jennings's work include Mechanical Circulatory Support Devices (59 papers), Cardiac Structural Anomalies and Repair (43 papers) and Transplantation: Methods and Outcomes (28 papers). Douglas L. Jennings is often cited by papers focused on Mechanical Circulatory Support Devices (59 papers), Cardiac Structural Anomalies and Repair (43 papers) and Transplantation: Methods and Outcomes (28 papers). Douglas L. Jennings collaborates with scholars based in United States, United Kingdom and Iran. Douglas L. Jennings's co-authors include James S. Kalus, Craig I Coleman, Jerry Yee, David M. Salerno, Phillip Weeks, Jeffrey A. Morgan, Maryjane Farr, Koji Takeda, P.C. Colombo and David E. Lanfear and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of the American Geriatrics Society and American Journal of Kidney Diseases.

In The Last Decade

Douglas L. Jennings

103 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas L. Jennings United States 19 627 539 447 275 132 108 1.2k
James B. McClurken United States 16 606 1.0× 205 0.4× 528 1.2× 99 0.4× 142 1.1× 42 1.1k
Kimberly N. Hong United States 24 1.4k 2.3× 840 1.6× 657 1.5× 185 0.7× 337 2.6× 68 1.9k
Fabrizio Oliva Italy 17 366 0.6× 250 0.5× 1.1k 2.4× 145 0.5× 13 0.1× 87 1.4k
Michael Irlbeck Germany 20 353 0.6× 204 0.4× 269 0.6× 105 0.4× 31 0.2× 76 1.1k
Matthew E. Prekker United States 19 717 1.1× 279 0.5× 130 0.3× 524 1.9× 122 0.9× 86 1.5k
Shivank Madan United States 16 330 0.5× 226 0.4× 261 0.6× 103 0.4× 100 0.8× 53 727
Deane E. Smith United States 19 557 0.9× 331 0.6× 190 0.4× 140 0.5× 123 0.9× 88 1.1k
Vanessa Blumer United States 19 331 0.5× 280 0.5× 572 1.3× 189 0.7× 11 0.1× 87 909
Wisit Kaewput Thailand 18 255 0.4× 53 0.1× 159 0.4× 68 0.2× 100 0.8× 90 985
Jason Swindle United States 16 235 0.4× 70 0.1× 425 1.0× 60 0.2× 140 1.1× 39 782

Countries citing papers authored by Douglas L. Jennings

Since Specialization
Citations

This map shows the geographic impact of Douglas L. Jennings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas L. Jennings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas L. Jennings more than expected).

Fields of papers citing papers by Douglas L. Jennings

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas L. Jennings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas L. Jennings. The network helps show where Douglas L. Jennings may publish in the future.

Co-authorship network of co-authors of Douglas L. Jennings

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas L. Jennings. A scholar is included among the top collaborators of Douglas L. Jennings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas L. Jennings. Douglas L. Jennings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuzefpolskaya, M., et al.. (2024). The Impact of Statin Intensity on the Early Progression of Cardiac Allograft Vasculopathy. Clinical Transplantation. 38(11). e70030–e70030.
2.
Jennings, Douglas L., et al.. (2024). Ivabradine Approved and Other Uses in Clinical Practice: A Systematic Review. Journal of Cardiovascular Pharmacology. 84(3). 276–288. 1 indexed citations
3.
Talasaz, Azita H., Parham Sadeghipour, Sina Rashedi, et al.. (2024). Pharmacokinetic and Pharmacodynamic Interactions between Food or Herbal Products and Oral Anticoagulants: Evidence Review, Practical Recommendations, and Knowledge Gaps. Seminars in Thrombosis and Hemostasis. 51(5). 560–571. 8 indexed citations
4.
Salerno, David M., et al.. (2024). Contemporary Immunosuppression Management and 1‐Year Outcomes in Dual Organ Heart Transplantation. Clinical Transplantation. 38(8). e15420–e15420.
5.
Barreto, Jason N., James C. Coons, Kellie J. Goodlet, et al.. (2023). Best practices for supporting and improving pharmacy resident research and quality improvement projects. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 7(1). 75–84. 2 indexed citations
6.
Pinsino, A., Syed Akhtar Husain, Sumit Mohan, et al.. (2023). The Difference Between Cystatin C– and Creatinine-Based Estimated GFR in Heart Failure With Reduced Ejection Fraction: Insights From PARADIGM-HF. American Journal of Kidney Diseases. 82(5). 521–533. 17 indexed citations
7.
Lange, Nicholas W., David M. Salerno, Ersilia M. DeFilippis, et al.. (2022). COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era. American Journal of Transplantation. 22(11). 2682–2688. 33 indexed citations
8.
Salerno, David M., Douglas L. Jennings, Nicholas W. Lange, et al.. (2022). Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients. American Journal of Transplantation. 22(8). 2083–2088. 57 indexed citations
9.
Beavers, Craig J., Robert J. DiDomenico, Steven P. Dunn, et al.. (2021). Optimizing anticoagulation for patients receiving Impella support. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(11). 932–942. 24 indexed citations
10.
Jennings, Douglas L., et al.. (2021). Impact of heart failure drug therapy on rates of gastrointestinal bleeding in LVAD recipients: An INTERMACS analysis. The International Journal of Artificial Organs. 44(12). 965–971. 11 indexed citations
11.
Liu, Esther, et al.. (2020). Immunosuppression considerations in simultaneous organ transplant. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(1). 59–76. 8 indexed citations
12.
Doligalski, Christina T., et al.. (2020). Pharmacotherapy for durable left ventricular assist devices. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(1). 14–27. 6 indexed citations
13.
Reed, Brent N., Robert J. DiDomenico, J. Erin Allender, et al.. (2019). Survey of Anticoagulation Practices with the Impella Percutaneous Ventricular Assist Device at High-Volume Centers. Journal of Interventional Cardiology. 2019. 1–6. 23 indexed citations
14.
Lange, Nicholas W., William L. Baker, M. Shullo, et al.. (2018). Outcomes Associated With Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-analysis. The Journal of Heart and Lung Transplantation. 37(4). S90–S91. 1 indexed citations
15.
Jennings, Douglas L., et al.. (2014). Epidemiology and Outcomes Associated With Anemia During Long-Term Support With Continuous-Flow Left Ventricular Assist Devices. Journal of Cardiac Failure. 20(6). 387–391. 17 indexed citations
16.
Williams, Celeste T., Douglas L. Jennings, Cristina Tita, et al.. (2012). ANALYSIS OF COST FOR READMISSIONS AFTER CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION-A SINGLE CENTER EXPERIENCE. Journal of the American College of Cardiology. 59(13). E1018–E1018. 2 indexed citations
17.
Peters, Michael, et al.. (2012). Reversal of dabigatran-induced bleeding with a prothrombin complex concentrate and fresh frozen plasma. American Journal of Health-System Pharmacy. 69(19). 1646–1650. 47 indexed citations
18.
Jennings, Douglas L., et al.. (2012). Successful Treatment of a Continuous Flow Left Ventricular Assist Device Thrombosis With Eptifibatide.. ASAIO Journal. 58(6). 633–635. 12 indexed citations
19.
Jennings, Douglas L., et al.. (2007). Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta‐analysis. Diabetic Medicine. 24(5). 486–493. 97 indexed citations
20.
Burns, J, et al.. (1983). Progressive oropharyngeal dysfunction in a dog. Journal of the American Veterinary Medical Association. 183(9). 1009–1011. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James B. McClurken Breakdown of academic impact, for papers by Kimberly N. Hong Breakdown of academic impact, for papers by Fabrizio Oliva Breakdown of academic impact, for papers by Michael Irlbeck Breakdown of academic impact, for papers by Matthew E. Prekker Breakdown of academic impact, for papers by Shivank Madan Breakdown of academic impact, for papers by Deane E. Smith Breakdown of academic impact, for papers by Vanessa Blumer Breakdown of academic impact, for papers by Wisit Kaewput Breakdown of academic impact, for papers by Jason Swindle
Rankless by CCL
2026